Get the app!
Back to Trades

Taylor Ben R

Chief Financial OfficerCIK 0001712276

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
13
Buy transactions
0
Sell transactions
3
Companies
1
Active
2025–2026

Taylor Ben R, Chief Financial Officer, has filed 13 SEC reports (2025–2026), all concentrated in RECURSION PHARMACEUTICALS, INC. (RXRX), totaling $780.6K in disclosed volume. Weighing $0 bought versus $157.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

13 loaded
Aug 18RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$79.1K
Jun 17RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$17.0K
May 19RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$76.1K
Apr 8RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$149.4K
Mar 18RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerSell$27.0K
Feb 19RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerSell$41.4K
Feb 10RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerGrant$45.4K
Dec 30RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerSell$89.4K
Dec 17RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$30.6K
Nov 26RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$9.2K
Nov 19RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$49.3K
Sep 17RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$34.1K
Aug 19RXRX
RECURSION PHARMACEUTICALS, INC.
Taylor Ben RChief Financial OfficerTax withheld$67.2K

13 filings